‘You Don’t Put Your Head in the Sand for 4 Years’: Colossal CEO Ben Lamm on Working With Trump
The company’s cofounder recently convinced the Trump administration to support an initiative to gather DNA samples from endangered species.
An AI Agent Injected Drugs Into a Live Mouse’s Brain
A biotech startup let an agent choose a gene therapy and successfully inject the treatment, offering a startling glimpse of the future of research labs.
Anthropic Says It Will Revolutionize Biology—Some Day
In breathless press releases and posts, the company has touted its models’ ability to deliver scientific breakthroughs. But its IPO filing taps the brakes on just how fast its AI will lead to big discoveries.
Inside the Exclusive Nathan Fielder Interview
This week on “Uncanny Valley,” we go behind the scenes of our Nathan Fielder cover story, unpack tech billionaires’ generous promises, and discuss the suspicious letters sent to US election offices.
OpenAI Invests in Startup That Uses Brain Implants to Detect Cancer
It’s the latest in a growing wave of bets that AI companies are making on brain data.
Why AI Isn’t Ready to Tackle Our Convoluted Genomes
The DNA inside our cells isn’t just a series of instructions, but something far more dynamic. Like scientists, AI models don't yet have the data to properly decode it.
Life Is Asymmetric. The Scientists Who Figured Out Why Won the 2026 Nobel Prize in Chemistry
Henri Kagan and Kensō Soai designed chemical reactions producing only one of the two mirror-image forms of a molecule—an important finding for the synthesis of pharmaceuticals and other biological substances.
A New Neurotech Startup Launches to Rival Sam Altman’s Merge Labs
Bridge Neurotech is planning to build a wearable brain-computer interface that uses ultrasound.
There Are Plenty of Reasons to Be Concerned About Bioweapons Development—Even Without AI
In her new book on biological warfare, Annie Jacobsen didn’t even discuss AI because scientists can already warp Mother Nature to create extinction-level events.
A Biotech Founder Makes the Moral Case for Gene-Editing Human Embryos
The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a “moral imperative” to address hereditary diseases.